Discovery of L-791,943: A potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor

This publication has 19 references indexed in Scilit:

• Genomic organization of the human phosphodiesterase PDE11A gene
  European Journal of Biochemistry, 2001
• House Dust Mite–induced Airway Changes in hu-SCID Mice
  American Journal of Respiratory and Critical Care Medicine, 2000
• ArifloTM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to Clinic
  Pulmonary Pharmacology & Therapeutics, 1999
• Expired Nitric Oxide and Airway Obstruction in Asthma Patients with an Acute Exacerbation
  American Journal of Respiratory and Critical Care Medicine, 1999
• The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor‐α and leukotriene B₄ in a novel human whole blood assay
  British Journal of Pharmacology, 1999
• Effects of a selective phosphodiesterase IV inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma
  Canadian Journal of Physiology and Pharmacology, 1998
• Phosphodiesterase Isozymes
  American Journal of Respiratory and Critical Care Medicine, 1998
• The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4
  British Journal of Pharmacology, 1996
• The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep
  European Journal of Pharmacology, 1992
• Cyclic AMP-dependent Regulation of Lipid Mediators in White Cells: A Unifying Concept for Explaining the Efficacy of Theophylline in Asthma
  American Review of Respiratory Disease, 1987